In January 2025, regulators added warnings about severe gastrointestinal adverse reactions, acknowledging that the slowed gastric emptying mechanism can lead to far more serious consequences than initially disclosed
Frequency not known : Bowel obstruction (severe constipation) symptoms include bloating, vomiting, stomach ache and not being able to pass wind or open your bowels
Presented for research literature review only Wulff BS et al
Dose and Duration of treatment
Buying a weight loss ETF means at once buying a diversified portfolio of stocks purely exposed to GLP-1 and obesity
We acknowledge that there were some differences in the comparison between GLP-1RAs and other glucose-lowering agents, particularly concerning HbA 1c levels, the use of insulin and the use of SGLT2 inhibitors, which may have influenced the results